
PharmaLundensis Investor Relations Material
Latest events

Q2 2025
21 Aug, 2025

Q1 2025
15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PharmaLundensis
Access all reports
PharmaLundensis AB is a Sweden-based biotechnology company focused on developing treatments and solutions for respiratory diseases. The company specializes in research aimed at addressing chronic obstructive pulmonary disease (COPD) and related conditions. In addition to its pharmaceutical development activities, PharmaLundensis explores environmentally friendly methods for reducing medical waste and chemical emissions in healthcare. The company is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
PHAL
Country
🇸🇪 Sweden